Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent
March 15 2021 - 8:00AM
Syneos Health Communications – the portfolio of Syneos Health®
agencies designed to deliver insights-driven integrated
communications spanning advertising, public relations, patient
advocacy, medical communications, managed markets, omnichannel,
naming and branding – has added seasoned global talent to lead
creative expression and strategy in communications that drive
positive health outcomes.
Syneos Health Communications, including the market-leading
healthcare advertising agency GSW, translates complex information
into clear, actionable solutions to enable audiences to make
informed, confident decisions. These health-first, health-only
agencies deploy a wide array of strategic capabilities, with a
direct line to 25,000 Syneos Health clinical and commercial minds,
to bring breakthrough healthcare to the world.
“From launching a new treatment in a crowded space, to
rethinking how a treatment can target a new audience, we weave
together the power of technology, communications and humanity,”
said JD Cassidy, President, Advertising, for Syneos Health
Communications. “This new group of leaders includes some of the
industry’s most creative minds, disrupters and change masters –
skilled at breathing life into our customers’ innovations and our
colleagues’ work – to make the strongest impact on the right
audiences.”
Three senior hires joining Syneos Health Communications
include:
Orrin Pollard, Director of European Creative
Expression, has more than 25 years of experience leading
creative teams across every therapeutic area in the health and
wellness space. He was the founder and creative director of DDB
Remedy UK, and has created and inspired numerous
multi-award-winning national OTC and global ethical campaigns
across Europe. Orrin has served as a judge on many international
awards panels including Cannes Lions, Clio Health & Eurobest,
and his work has been recognized by Cannes Lions, Clio Health,
D&AD, LIAA, PM Society Digital Awards and The Globals, among
others.
Christina Pantelias, EVP of Strategy, GSW New
York, is an executive leader with decades of experience
turning information into insights that build brands. She is
passionate about the theory and practice of connecting people with
brands and is known for building high-performing teams. She
previously ran Strategic Planning for Arnold’s DC and St. Louis
offices, and has worked on a wide range of categories and blue chip
brands including Kellogg’s, Johnson & Johnson, Merck, P&G,
and Novo Nordisk, among others.
Carolyn Gargano, SVP, Creative
Director, GSW West Coast, joins with over 20 years of
experience in the health and wellness space, partnering with
clients across a deep roster of domestic and global brands. She
will lead agency-wide initiatives that champion creativity, with a
passion for social purpose campaigns that make the world a
healthier place. She previously held roles at W2O, Area 23, Saatchi
& Saatchi Wellness, FCB and Deutsch, in addition to Chandler
Chicco Agency, a Syneos Health Communications agency.
This new trio of creative leaders will work across Syneos Health
Communications to bring science to life in service of the
healthcare industry, scientists, clinicians, manufacturers and
patients. They’ll provide a clear, definitive, and persuasive voice
to accelerate research and innovation to improve the health and
well-being of society.
Syneos Health Communications agencies work in scalable,
purpose-built teams that partner across disciplines and geographies
to accelerate brand performance. The portfolio includes GSW, GSW
Managed Markets, Chandler Chicco Agency, Biosector 2, Chamberlain
Healthcare Communications, Managed Markets Communications, Navicor,
Cadent Medical Communications and Addison Whitney, among
others.
About Syneos HealthSyneos
Health® (Nasdaq:SYNH) is the only fully integrated
biopharmaceutical solutions organization. The Company, including a
Contract Research Organization (CRO) and Contract Commercial
Organization (CCO), is purpose-built to accelerate customer
performance to address modern market realities. We bring together
approximately 25,000 clinical and commercial minds with the ability
to support customers in more than 110 countries. Together we share
insights, use the latest technologies and apply advanced business
practices to speed our customers’ delivery of important therapies
to patients. To learn more about how we are Shortening the
distance from lab to life®, visit syneoshealth.com or
subscribe to our podcast.
Investor Relations Contact: Ronnie Speight Senior
Vice President, Investor Relations+1 919 745 2745
Investor.Relations@syneoshealth.com |
Press/Media Contact: Gary Gatyas Executive
Director, External Communications +1 908 763
3428 gary.gatyas@syneoshealth.com |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024